vs
Side-by-side financial comparison of Guardian Pharmacy Services, Inc. (GRDN) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $208.9M, roughly 1.9× iRhythm Holdings, Inc.). Guardian Pharmacy Services, Inc. runs the higher net margin — 5.3% vs 2.7%, a 2.6% gap on every dollar of revenue.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
GRDN vs IRTC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $397.6M | $208.9M |
| Net Profit | $20.9M | $5.6M |
| Gross Margin | 21.5% | 70.9% |
| Operating Margin | 7.7% | 1.1% |
| Net Margin | 5.3% | 2.7% |
| Revenue YoY | — | 27.1% |
| Net Profit YoY | — | 518.5% |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $397.6M | $208.9M | ||
| Q3 25 | $377.4M | $192.9M | ||
| Q2 25 | $344.3M | $186.7M | ||
| Q1 25 | $329.3M | $158.7M | ||
| Q4 24 | — | $164.3M | ||
| Q3 24 | $314.4M | $147.5M | ||
| Q2 24 | — | $148.0M | ||
| Q1 24 | — | $131.9M |
| Q4 25 | $20.9M | $5.6M | ||
| Q3 25 | $9.8M | $-5.2M | ||
| Q2 25 | $9.0M | $-14.2M | ||
| Q1 25 | $9.4M | $-30.7M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | $-122.0M | $-46.2M | ||
| Q2 24 | — | $-20.1M | ||
| Q1 24 | — | $-45.7M |
| Q4 25 | 21.5% | 70.9% | ||
| Q3 25 | 19.8% | 71.1% | ||
| Q2 25 | 19.8% | 71.2% | ||
| Q1 25 | 19.5% | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | 19.4% | 68.8% | ||
| Q2 24 | — | 69.9% | ||
| Q1 24 | — | 66.3% |
| Q4 25 | 7.7% | 1.1% | ||
| Q3 25 | 4.3% | -4.4% | ||
| Q2 25 | 3.7% | -10.0% | ||
| Q1 25 | 3.9% | -20.5% | ||
| Q4 24 | — | -2.5% | ||
| Q3 24 | -33.3% | -34.1% | ||
| Q2 24 | — | -15.5% | ||
| Q1 24 | — | -28.9% |
| Q4 25 | 5.3% | 2.7% | ||
| Q3 25 | 2.6% | -2.7% | ||
| Q2 25 | 2.6% | -7.6% | ||
| Q1 25 | 2.9% | -19.3% | ||
| Q4 24 | — | -0.8% | ||
| Q3 24 | -38.8% | -31.3% | ||
| Q2 24 | — | -13.6% | ||
| Q1 24 | — | -34.6% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.44 | ||
| Q1 25 | — | $-0.97 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | — | $-1.48 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-1.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $583.8M |
| Total DebtLower is stronger | $0 | — |
| Stockholders' EquityBook value | $217.9M | $152.7M |
| Total Assets | $412.7M | $1.0B |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $583.8M | ||
| Q3 25 | $36.5M | $565.2M | ||
| Q2 25 | $18.8M | $545.5M | ||
| Q1 25 | $14.0M | $520.6M | ||
| Q4 24 | — | $535.6M | ||
| Q3 24 | $37.2M | $522.0M | ||
| Q2 24 | — | $561.5M | ||
| Q1 24 | — | $569.1M |
| Q4 25 | $0 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $217.9M | $152.7M | ||
| Q3 25 | $195.5M | $121.9M | ||
| Q2 25 | $179.7M | $103.7M | ||
| Q1 25 | $163.2M | $86.7M | ||
| Q4 24 | — | $90.9M | ||
| Q3 24 | $133.9M | $71.8M | ||
| Q2 24 | — | $99.2M | ||
| Q1 24 | — | $90.3M |
| Q4 25 | $412.7M | $1.0B | ||
| Q3 25 | $390.0M | $995.2M | ||
| Q2 25 | $356.3M | $964.0M | ||
| Q1 25 | $334.0M | $926.1M | ||
| Q4 24 | — | $931.4M | ||
| Q3 24 | $348.0M | $909.7M | ||
| Q2 24 | — | $919.2M | ||
| Q1 24 | — | $909.8M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.6M | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 1.65× | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.6M | $26.2M | ||
| Q3 25 | $28.2M | $34.9M | ||
| Q2 25 | $19.9M | $27.7M | ||
| Q1 25 | $17.6M | $-7.9M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | — | $24.3M | ||
| Q2 24 | — | $11.8M | ||
| Q1 24 | — | $-52.0M |
| Q4 25 | — | $14.5M | ||
| Q3 25 | $24.2M | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $-61.8M |
| Q4 25 | — | 6.9% | ||
| Q3 25 | 6.4% | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -46.8% |
| Q4 25 | — | 5.6% | ||
| Q3 25 | 1.1% | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | 1.65× | 4.70× | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 2.21× | — | ||
| Q1 25 | 1.86× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRDN
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
